Zwi N Berneman

Trials

Studies that name Zwi N Berneman as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:18 UTC. Open this list on ClinicalTrials.gov

• Ph1/Ph2
  NCT05765084 · Integration of the PD-L1 Inhibitor Atezolizumab and WT1/DC Vaccination Into Platinum/Pemetrexed-based First-line Treatment for Epithelioid Malignant Pleural Mesothelioma

  University Hospital, Antwerp · recruiting · Malignant Pleural Mesothelioma · study director
• Ph1/Ph2
  NCT04911621 · Adjuvant Dendritic Cell Immunotherapy for Pediatric Patients With High-grade Glioma or Diffuse Intrinsic Pontine Glioma

  University Hospital, Antwerp · completed · High Grade Glioma, Diffuse Intrinsic Pontine Glioma · principal investigator
• Ph1/Ph2
  NCT02649829 · Autologous Dendritic Cell Vaccination in Mesothelioma

  University Hospital, Antwerp · completed · Malignant Pleural Mesothelioma · study director
• Ph1/Ph2
  NCT02649582 · Adjuvant Dendritic Cell-immunotherapy Plus Temozolomide in Glioblastoma Patients

  University Hospital, Antwerp · active not recruiting · Glioblastoma Multiforme of Brain · study director

Grants

NIH projects from RePORTER, fetched 2026-11-12 11:18 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.